Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.
Antimycobacterial Susceptibility Testing Group;
(2022)
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.
European Respiratory Journal, 59 (4).
p. 2200166.
ISSN 0903-1936
DOI: 10.1183/13993003.00166-2022
Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6
-
picture_as_pdf - ASTG_2022_Updating-the-approaches-to-define.pdf
-
subject - Published Version
-
- Available under Creative Commons: 4.0
Downloads